603259 藥明康德
按盤價 
65.270 +0.340 (+0.524%) | 2025/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 9,654,595 | 20.96% | 39,241,431 | 40,340,807 | 39,354,778 | 22,902,385 | |
| 減：營業總成本 | 6,712,129 | 18.93% | 27,342,268 | 28,708,591 | 29,800,811 | 18,574,516 | |
| 其中:營業成本 | 5,574,529 | 12.88% | 22,964,515 | 23,728,800 | 24,677,217 | 14,592,256 | |
| 財務費用 | 71,608 | -116.87% | (786,684) | (338,119) | (247,968) | 84,082 | |
| 資產減值損失 | (156,213) | -2,468.77% | (1,236,258) | (156,509) | (175,951) | (33,056) | |
| 公允價值變動收益 | (45,939) | -45.32% | 186,958 | (37,809) | 770,079 | (93,387) | |
| 投資收益 | 1,537,653 | -17,328.41% | 604,162 | 233,849 | 187,949 | 1,356,269 | |
| 其中：對聯營企業和合營企業的投資收益 | 64,003 | 87.45% | 245,065 | (67,560) | (46,271) | (117,290) | |
| 營業利潤 | 4,292,749 | 85.85% | 11,580,175 | 11,872,286 | 10,652,249 | 6,037,725 | |
| 利潤總額 | 4,279,894 | 86.29% | 11,539,812 | 11,831,991 | 10,618,476 | 6,015,609 | |
| 減：所得稅費用 | 564,425 | 66.72% | 1,972,072 | 2,131,731 | 1,715,866 | 879,662 | |
| 淨利潤 | 3,715,469 | 89.68% | 9,567,740 | 9,700,260 | 8,902,611 | 5,135,947 | |
| 減：非控股權益 | 43,508 | 161.43% | 117,431 | 93,511 | 88,898 | 38,792 | |
| 股東淨利潤 | 3,671,961 | 89.06% | 9,450,308 | 9,606,749 | 8,813,713 | 5,097,155 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.290 | 92.54% | 3.280 | 3.270 | 3.010 | 1.750 | |
| 每股派息 (元) * | 0.350 | -- | 0.982 | 0.990 | 0.893 | 0.517 | |
| 每股淨資產 (元) * | 21.583 | 13.79% | 20.302 | 18.570 | 15.737 | 13.020 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 20/06/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
